Pathways to enhancing prenatal diagnosis of skeletal dysplasias
Abstract Skeletal dysplasias are a group of Mendelian disorders that variably alter the development of the musculoskeletal system and phenotypically range from mild short stature syndromes to severe perinatal or neonatal morbidity. Prenatal diagnosis of these conditions can be challenging due to the lack of precision with ultrasound imaging compared to postnatal radiographs as well as the known allelic heterogeneity and phenotypic variability underlying these conditions. Historically, the sonographic approach for phenotyping these conditions lacked genotypic specificity and counseling focused on predicting perinatal lethality. However, recent advances in genomic medicine and prenatal ultrasound resolution have enabled more precise diagnosis and individualized counseling. The following review provides a comprehensive overview of best practices for prenatal ultrasonography and molecular work‐up for skeletal dysplasias and provides a standardized evidence‐based framework for evaluation.
Authors
- Michelle J. Wang (ORCID: https://orcid.org/0000-0002-5177-8109)
- Ronald J. Wapner (ORCID: https://orcid.org/0000-0003-0727-1244)
- Christina Jacobsen
- Jennifer Arnold
- Deborah Krakow (ORCID: https://orcid.org/0000-0001-9906-4968)
Institutions
- Boston Children's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of California, Los Angeles (US)
- Columbia University Irving Medical Center (US)
Publication Details
- Journal
- Pregnancy
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1002/pmf2.70284
- Citations
- 1
- Primary Topic
- Connective tissue disorders research
- Type
- article
- Field-Weighted Citation Impact
- 18.99
Funders
- National Institutes of Health
- National Institute of General Medical Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development